[EN] INDOLAMID DERIVATIVES WHICH POSSESS GLYCOGENPHOSPHORYLASE INHIBITORY ACTIVITY<br/>[FR] DERIVES D'INDOLAMIDE PRESENTANT UNE ACTIVITE INHIBITRICE DE LA GLYCOGENE PHOSPHORYLASE
申请人:ASTRAZENECA AB
公开号:WO2003074484A1
公开(公告)日:2003-09-12
Heterocyclic amides of formula (1) wherein: is a single or double bond;A is phenylene or heteroarylene;m is 0, 1 or 2;n is 0, 1 or 2;R1 is selected from for example halo, nitro, cyano, hydroxy, carboxy; r is 1 or 2; Y is -NR2R3 or -OR3;R2 and R3 are selected from for example hydrogen, hydroxy, aryl, heterocyclyl and C 1-4 alkyl(optionally substituted by 1 or 2 R8 groups);R4 is selected from for example hydrogen, halo, nitro, cyano, hydroxy, C 1-4 alkyl, and C 1-4 alkanoyl; R8 is selected from for example hydroxy, -COCOOR9, -C(O)N(R9)(R10), -NHC(O)R9 , (R9)(R10)N- and -COOR9 ;R9 and R10 are selected from for example hydrogen, hydroxy, C 1-4 alkyl (optionally substituted by 1 or 2 R13 );R13 is selected from hydroxy, halo, trihalomethyl and C 1-4 alkoxy;or a pharmaceutically acceptable salt or pro-drug thereof; possess glycogen phosphorylase inhibitory activity and accordingly have value in the treatment of disease states associated with increased glycogen phosphorylase activity. Processes for the manufacture of said heterocyclic amide derivatives and pharmaceutical compositions containing them are described.
式(1)中的杂环酰胺,其中:是单键或双键;A是苯基或杂环基;m为0、1或2;n为0、1或2;R1从卤素、硝基、氰基、羟基、羧基等中选择;r为1或2;Y为-NR2R3或-OR3;R2和R3从氢、羟基、芳基、杂环基和C1-4烷基(可选地由1或2个R8基取代)中选择;R4从氢、卤素、硝基、氰基、羟基、C1-4烷基和C1-4烷酰基中选择;R8从羟基、-COCOOR9、-C(O)N(R9)(R10)、-NHC(O)R9、(R9)(R10)N-和-COOR9中选择;R9和R10从氢、羟基、C1-4烷基(可选地由1或2个R13基取代)中选择;R13从羟基、卤素、三卤甲基和C1-4烷氧基中选择;或其药学上可接受的盐或前药;具有糖原磷酸化酶抑制活性,因此在治疗与糖原磷酸化酶活性增加相关的疾病状态中具有价值。描述了制备所述杂环酰胺衍生物的方法以及含有它们的药物组合物。